The Canadian Advantage
Advantages for Companies to Conduct Clinical Trials in Canada
Conducting clinical trials in Canada offers several advantages for US-based companies, including cost savings, a streamlined regulatory process, and access to diverse patient populations, similar to that in the US. Canada’s regulatory framework, overseen by Health Canada, is well-aligned with the FDA, allowing for easier cross-border approvals and data acceptance. Additionally, clinical trial costs, including investigator fees and site expenses, are generally lower than in the US, providing significant financial benefits.
Tax Credits for R&D, innovation and pre-commercialization (“CRIC”)
KreaMedica
Operational and Financial Benefits
By working with KreaMedica, Sponsors can streamline operations, reduce administrative overhead and accelerate timelines, which translates to financial savings. With KreaMedica’s expertise in navigating Health Canada’s regulatory framework, and its established relationships with top-tier research institutions, US companies can achieve high-quality, cost-effective clinical trial execution while maintaining compliance with FDA standards. Furthermore, a collaboration with KreaMedica allows companies to take advantage of Canada’s supportive Tax Credits for R&D, innovation and pre-commercialization (CRIC) program, which further reduces trial costs.